1 deck published between 2024-03-14 and 2024-03-14 — 30 pages, 29 analysed slides total.
Each deck in chronological order — click to open. This is the story of the campaign as it unfolded.
Enfusion is a no-moat SaaS with tainted leadership, deteriorating unit economics, and revenue-reporting anomalies; Spruce Point sees 40-60% downside to $3.70-$5.60.